Galderma Group AG (GDERF)
Galderma Group Market Cap : 45.96B for March 4, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roche Holding AG | 368.60B |
| EvoNext Holdings SA | 8.438M |
| Kuros Biosciences Ltd. | 1.254B |
| Basilea Pharmaceutica AG | 871.29M |
Market Cap Related Metrics
| PS Ratio | 9.995 |
| PEG Ratio | 0.0132 |
| Price to Free Cash Flow | 63.57 |
| Price | 195.72 |
| Earnings Yield | 0.81% |
| PEGY Ratio | 0.0132 |
| Operating PE Ratio | 64.19 |
| Normalized PE Ratio | 111.36 |